The diagnosis of heart failure is more often missed than made especially for women

Greater Glasgow & Clyde Population Analysis presented in a late breaking science session today at Heart Failure 2023

2023-05-22

(Press-News.org) Prague, Czechia – 22 May 2023: The diagnosis of heart failure is usually missed, denying patients treatments that could improve wellbeing and reduce mortality. That’s the finding from a late breaking science presentation today at Heart Failure 2023, a scientific congress of the European Society of Cardiology (ESC).1

“For patients with heart failure, lifestyle advice, medicines and devices can improve symptoms, reduce morbidity and prolong life but this requires someone to recognise and diagnose the condition,” said principal investigator Professor John Cleland of the University of Glasgow, UK. “The earlier the diagnosis, the more effective treatment is likely to be. However, the results of this analysis suggest that most patients with heart failure die without the diagnosis ever being recognised.”

Many patients with heart failure have symptoms and signs for years before the diagnosis is finally made, which is usually only after the breathlessness and ankle swelling become severe enough to require hospitalisation.2 ESC Guidelines recommend loop diuretics to treat symptoms and signs of congestion due to heart failure.3 Accordingly, loop diuretics might be considered a surrogate for symptoms and signs of heart failure requiring further investigation.

Professor Cleland said: “My colleagues and I noticed that many patients without a diagnosis of heart failure were treated with loop diuretics in an international trial of atrial fibrillation.4 Prognosis was more strongly related to the use of loop diuretics than to a diagnosis of heart failure. We subsequently showed similar results in an international trial of type 2 diabetes.5 We suspected that many patients taking loop diuretics had heart failure but it had just not been recognised.”

Electronic health records for around one million adults in the Greater Glasgow and Clyde area of Scotland were used to investigate the relationship between a diagnosis of heart failure, loop diuretic dispensing and prognosis. At baseline (2010/11), 13,000 adults (1.3%) had a diagnosis of heart failure, a prevalence similar to the UK average,6 but 31,807 (3.2%) were receiving loop diuretics. Only one-quarter of those receiving loop diuretics (7,844 patients; 25%) had been diagnosed with heart failure. Patients taking loop diuretics were of similar age whether or not they had a heart failure diagnosis. However, 70% of those taking loop diuretics without a diagnosis were women whereas only 50% of those who also had a diagnosis of heart failure were women.

Further analyses were conducted in 198,898 participants receiving treatment for a broad range of cardiovascular diseases, mainly hypertension, coronary artery disease or heart failure, or taking loop diuretics only between 2010 and 2011. Patients were classified into one of four groups: 1) loop diuretics alone (23,963 patients; 12%), 2) heart failure diagnosis alone (5,156; 3%), 3) both (7,844; 4%), or 4) neither (161,935; 81%).

Over the next five years, for patients who were neither taking loop diuretics nor had a diagnosis of heart failure at baseline (Group 4), three times more (9%) started taking loop diuretics than were diagnosed with heart failure (3%). Few patients initiated on loop diuretics, predominantly by primary care physicians, were investigated for heart failure by echocardiography or by measuring natriuretic peptides, although many had blood samples taken for other tests such as haemoglobin or creatinine. People taking loop diuretics at baseline were more likely to be diagnosed with heart failure in the following five years (11%) than people not taking loop diuretics at baseline (3%).

By five years, about 35,000 (18%) people included in the cohort had died; 23% of these deaths were preceded by a diagnosis of heart failure (86% also treated with loop diuretics) while 32% were preceded by initiation of loop diuretics but without a diagnosis of heart failure. Of patients dispensed loop diuretics without a diagnosis of heart failure at baseline, 40% died during follow-up but only 11% received a new diagnosis of heart failure. Professor Cleland said: “While some patients taking loop diuretics were eventually told they had heart failure, many more died without ever receiving a diagnosis and therefore the opportunity for treatments to improve their outcome.”

Professor Cleland concluded: “It is likely that many patients treated with loop diuretics have undiagnosed heart failure. It is also possible that inappropriate use of loop diuretics is driving adverse outcomes. Any patient treated with loop diuretics should be investigated for serious underlying heart disease, either by measuring natriuretic peptides or doing an echocardiogram or both. The combination of undiagnosed heart failure and inappropriate loop diuretic use may be one of the largest and most serious problems that cardiologists have yet to tackle. Ignoring it and hoping it goes away would be a tragedy.”

ENDS

Authors: ESC Press Office
Tel: +33 (0)489 872 075

Email: press@escardio.org

Follow us on Twitter @ESCardioNews

Notes to editor

Funding: This work was partly funded by a PhD scholarship awarded to Jocelyn M. Friday and partly by a British Heart Foundation Centre of Research Excellence award (grant number RE/18/6/34217).

Disclosures: None direct. Professor Cleland has received many grants unrelated to this work from both commercial and non-commercial sources and honoraria for work on committees and for lectures and advisory boards.

References and notes

1The Greater Glasgow & Clyde Population Study will be presented during the session ‘Late breaking clinical trials: epidemiology and registries’ which takes place on 22 May at 15:00 CEST in Room 3.

2Cleland JGF, Pfeffer MA, Clark AL, et al. The struggle towards a Universal Definition of Heart Failure-how to proceed? Eur Heart J. 2021;42:2331–2343.

3McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42:3599–3726.

4Cleland JGF, Shelton R, Nikitin N, et al. Prevalence of markers of heart failure in patients with atrial fibrillation and the effects of ximelagatran compared to warfarin on the incidence of morbid and fatal events: a report from the SPORTIF III and V trials. Eur J Heart Fail. 2007;9:730–739.

5Pellicori P, Fitchett D, Kosiborod MN, et al. Use of diuretics and outcomes in patients with type 2 diabetes: findings from the EMPA-REG OUTCOME trial. Eur J Heart Fail. 2021;23:1085–1093.

6Conrad N, Judge A, Tran J, et al. Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals. Lancet. 2018;391:572–580.

About Heart Failure 2023 & World Congress on Acute Heart Failure
Heart Failure is the annual congress of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).
#HeartFailure2023

About the Heart Failure Association

The Heart Failure Association (HFA) is a branch of the European Society of Cardiology (ESC). Its aim is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.

About the European Society of Cardiology

The European Society of Cardiology brings together health care professionals from more than 150 countries, working to advance cardiovascular medicine and help people lead longer, healthier lives.

Information for journalists about registration for Heart Failure 2023

Heart Failure 2023 takes place 20 to 23 May at the O2 universum in Prague, Czechia and online. Explore the scientific programme.

Free registration applies to accredited press. Credentials: A valid press card or appropriate letter of assignment with proof of three recent published articles. Read the ESC media and embargo policy. The ESC Press Office will verify the documents and confirm by email that your press accreditation is valid. The ESC Press Office decision is final regarding all press registration requests. END

ELSE PRESS RELEASES FROM THIS DATE:

Are you prone to feeling guilty? You may be less likely to take a bribe

2023-05-22

Bribery is among the most recognizable forms of corruption, and new research is shedding light on personality traits that could deter this behavior. Guilt-prone people are less likely to accept bribes, particularly when the act would cause obvious harm to other people. The research, published in Social Psychological and Personality Science, contributes to a growing body of literature on individual differences in corrupt behaviors. “Our results have important implications for current world events, particularly in the realm of politics and governance where corruption and bribery are major concerns,” says author Prof. Xiaolin Zhou, of East China Normal University. “More ...

Compound from magnolia tree bark impedes SARS-CoV-2 replication in certain cells

2023-05-22

Washington, DC – A compound called honokiol, which is found in the bark of multiple species of magnolia tree, inhibits replication of SARS-CoV-2 virus in several types of cells, according to a team of researchers in the Netherlands. The research is published in Microbiology Spectrum, a journal of the American Society for Microbiology. The researchers found that Honokiol inhibits replication of SARS-CoV-2 in several cell types, causing production of infectious SARS-CoV-2 particles in treated cells to fall to around 1,000th of the previous level. The compound also inhibited replication of other highly pathogenic human coronaviruses, including MERS- ...

Leadless pacemakers soon available for all patients

2023-05-22

Every year more than one million people receive a pacemaker. Until now, leadless versions were only available for 20% of these patients. However, thanks to an international consortium led by Amsterdam UMC, an improved version will soon be available for all patients. The results of this clinical trial are, today, published in the New England Journal of Medicine. Research from Amsterdam UMC has succeeded in further revolutionising the wireless pacemaker. The improved version can now be placed in both the atrium and the ventricle of ...

Siblings with autism share more of dad’s genome, not mom’s

2023-05-22

Cold Spring Harbor Laboratory (CSHL) researchers have flipped the script on autism spectrum disorder (ASD) genetics. Scientists long thought that siblings born with ASD share more of their mother’s genome than their father’s. But CSHL Associate Professor Ivan Iossifov and Professor Michael Wigler have now shown that, in many cases, it’s dad who might be playing a bigger genetic role. Autism spectrum disorders cover a range of neurological and developmental conditions. They can affect how a person communicates, socializes, learns, and behaves. ASD may also manifest as repetitive behaviors ...

Women more likely to die after heart attack than men

2023-05-22

Prague, Czechia – 22 May 2023: Women are more than twice as likely to die after a heart attack than men, according to research presented today at Heart Failure 2023, a scientific congress of the European Society of Cardiology (ESC).1 “Women of all ages who experience a myocardial infarction are at particularly high risk of a poor prognosis,” said study author Dr. Mariana Martinho of Hospital Garcia de Orta, Almada, Portugal. “These women need regular monitoring after their heart event, with strict control of blood pressure, ...

ASCO: Targeted therapy for early breast cancer, progress treating recurrent glioma, PSMA PET scan advances and more

2023-05-22

Physicians and scientists from the UCLA Jonsson Comprehensive Cancer Center will discuss the latest research and clinical trial results on combination therapies for breast cancer, a potential new treatment for patients with recurrent glioma, and advances in PSMA PET guided radiotherapy for patients with prostate cancer, among other topics, at the American Society of Clinical Oncology’s annual meeting. At this year’s scientific forum, Dr. Dennis Slamon, chair of hematology-oncology and director of clinical ...

Cancer researchers join forces against deadliest brain tumors in children

2023-05-22

Virginia Tech researchers with the Fralin Biomedical Research Institute at VTC have joined a Children’s National Hospital effort to treat deadly brain tumors with ultrahigh frequency sound waves. The scientists are studying how to use an emerging technology called focused ultrasound to fight diffuse midline glioma (DMG), one of the most lethal childhood brain cancers with a nearly 100 percent rate of mortality within five years of diagnosis. A multi-institutional team led by Javad Nazarian, a principal investigator with Children’s National Hospital, will study how to use focused ultrasound to create ...

Eruption of Tonga underwater volcano found to disrupt satellite signals halfway around the world

2023-05-22

An international team has used satellite- and ground-based ionospheric observations to demonstrate that an air pressure wave triggered by volcanic eruptions could produce an equatorial plasma bubble (EPB) in the ionosphere, severely disrupting satellite-based communications. Their findings were published in the journal Scientific Reports. The ionosphere is the region of the Earth's upper atmosphere where molecules and atoms are ionized by solar radiation, creating positively charged ions. The area with the highest concentration of ionized particles is called the F-region, an area 150 to 800 km above the Earth's surface. The F-region plays ...

Adverse pregnancy outcomes increase stroke risk

2023-05-22

Investigators from the Smidt Heart Institute at Cedars-Sinai found that women who experience an adverse pregnancy outcome—such as gestational hypertension, preeclampsia or preterm birth—have a higher risk of developing stroke in their lifetime, and at a younger age. The findings, published today in the peer-reviewed journal Stroke, also found that compared to women with one uncomplicated pregnancy, a woman who had two or more pregnancies impacted by an adverse pregnancy outcome had a twofold higher increase of stroke. “We understand from past studies in the U.S. that women have a greater risk of experiencing a stroke and a disproportionate ...

Earlier snowpack melt in the West could bring summer water scarcity

2023-05-22

Snow is melting earlier, and more rain is falling instead of snow in the mountain ranges of the Western U.S. and Canada, leading to a leaner snowpack that could impact agriculture, wildfire risk and municipal water supplies come summer, according to a new study from the University of Colorado Boulder. Published in Nature Communications Earth & Environment, the study documents more than 60 years of change in snowpack water storage across Western North America. It found that from 1950 to 2013, snowpack water storage ...